3-(6-(2-(2,6-DICHLOROBENZYLOXY)ETHOXY)HEXYL)-5-(2,2-DIMETHYL-4H-BENZO(1,3)DIOXIN-6-YL)OXAZOLIDIN-2-ONE, (R)-
UNII 8B67PMA54Q
Substance Identification & Data
This profile provides standardized clinical and technical data for 3-(6-(2-(2,6-dichlorobenzyloxy)ethoxy)hexyl)-5-(2,2-dimethyl-4h-benzo(1,3)dioxin-6-yl)oxazolidin-2-one, (r)-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 8B67PMA54Q.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 503068-36-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C28H35Cl2NO6 XQWNKZGGCAFXHI-SANMLTNESA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 3-(6-(2-(2,6-dichlorobenzyloxy)ethoxy)hexyl)-5-(2,2-dimethyl-4h-benzo(1,3)dioxin-6-yl)oxazolidin-2-one, (r)-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.